MA54378A - Composés hétéroaromatiques utilisés en tant qu'inhibiteurs de vanine - Google Patents
Composés hétéroaromatiques utilisés en tant qu'inhibiteurs de vanineInfo
- Publication number
- MA54378A MA54378A MA054378A MA54378A MA54378A MA 54378 A MA54378 A MA 54378A MA 054378 A MA054378 A MA 054378A MA 54378 A MA54378 A MA 54378A MA 54378 A MA54378 A MA 54378A
- Authority
- MA
- Morocco
- Prior art keywords
- compounds used
- heteroaromatic compounds
- vanin
- inhibitors
- vanin inhibitors
- Prior art date
Links
- 150000002390 heteroarenes Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/056—Triazole or tetrazole radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18209721 | 2018-12-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA54378A true MA54378A (fr) | 2022-03-09 |
Family
ID=64572152
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA054378A MA54378A (fr) | 2018-12-03 | 2019-12-02 | Composés hétéroaromatiques utilisés en tant qu'inhibiteurs de vanine |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US11078182B2 (fr) |
| EP (1) | EP3891139A1 (fr) |
| JP (2) | JP7130873B2 (fr) |
| KR (1) | KR20210100150A (fr) |
| CN (2) | CN113166104A (fr) |
| AR (1) | AR117229A1 (fr) |
| AU (1) | AU2019391279B2 (fr) |
| BR (1) | BR112021007915A2 (fr) |
| CA (1) | CA3116830A1 (fr) |
| CL (2) | CL2021001198A1 (fr) |
| CO (1) | CO2021007173A2 (fr) |
| CR (1) | CR20210294A (fr) |
| DO (1) | DOP2021000071A (fr) |
| EA (1) | EA202191476A1 (fr) |
| EC (1) | ECSP21040278A (fr) |
| IL (1) | IL283397B2 (fr) |
| JO (2) | JOP20210127A1 (fr) |
| MA (1) | MA54378A (fr) |
| MX (1) | MX2021006520A (fr) |
| PE (1) | PE20211769A1 (fr) |
| PH (1) | PH12021551280A1 (fr) |
| SA (1) | SA521422152B1 (fr) |
| SG (1) | SG11202104437XA (fr) |
| TW (1) | TWI838430B (fr) |
| UA (1) | UA128374C2 (fr) |
| WO (1) | WO2020114943A1 (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20210034A1 (ar) | 2018-08-28 | 2021-02-25 | Boehringer Ingelheim Int | مركبات عطرية غير متجانسة كمثبطات Vanin |
| WO2020113209A1 (fr) | 2018-11-30 | 2020-06-04 | Comet Therapeutics, Inc. | Dérivés de pantéthéine et leurs utilisations |
| BR112021007915A2 (pt) * | 2018-12-03 | 2021-07-27 | Boehringer Ingelheim International Gmbh | compostos heteroaromáticos utilizados como inibidores de vanina |
| JP7080405B2 (ja) | 2018-12-03 | 2022-06-03 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | バニン阻害剤としての複素芳香族化合物 |
| EA202191478A1 (ru) * | 2018-12-03 | 2021-10-26 | Бёрингер Ингельхайм Интернациональ Гмбх | Гетероароматические соединения в качестве ингибиторов ванина |
| US20230107927A1 (en) | 2020-02-28 | 2023-04-06 | First Wave Bio, Inc. | Methods of treating iatrogenic autoimmune colitis |
| EP4495120A4 (fr) * | 2022-03-18 | 2026-03-18 | Shanghai Meiyue Biotech Dev Co Ltd | Forme de sel et forme cristalline d'inhibiteur d'enzyme de vanine, leur procédé de préparation et leur utilisation |
| EP4683919A1 (fr) * | 2023-03-21 | 2026-01-28 | Athos Therapeutics, Inc. | Inhibiteurs de vanine-1 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030195192A1 (en) * | 2002-04-05 | 2003-10-16 | Fortuna Haviv | Nicotinamides having antiangiogenic activity |
| DE602004018811D1 (de) | 2003-10-09 | 2009-02-12 | Abbott Lab | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren |
| EP2900633A1 (fr) * | 2012-09-25 | 2015-08-05 | Merck Patent GmbH | Alpha-hydroxy-amides |
| EP3303303A1 (fr) | 2015-05-29 | 2018-04-11 | Pfizer Inc | Nouveaux composés hétérocycliques utilisés en tant qu'inhibiteurs de l'enzyme vanine-1 |
| BR112019000589A2 (pt) | 2016-07-14 | 2019-04-24 | Pfizer Inc. | pirimidina carboxamidas como inibidores da enzima vanina-1 |
| PE20200340A1 (es) | 2017-06-12 | 2020-02-14 | Boehringer Ingelheim Int | Compuestos heteroaromaticos como inhibidores de vanina |
| JOP20210034A1 (ar) | 2018-08-28 | 2021-02-25 | Boehringer Ingelheim Int | مركبات عطرية غير متجانسة كمثبطات Vanin |
| BR112021007915A2 (pt) * | 2018-12-03 | 2021-07-27 | Boehringer Ingelheim International Gmbh | compostos heteroaromáticos utilizados como inibidores de vanina |
| JP7080405B2 (ja) * | 2018-12-03 | 2022-06-03 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | バニン阻害剤としての複素芳香族化合物 |
| EA202191478A1 (ru) * | 2018-12-03 | 2021-10-26 | Бёрингер Ингельхайм Интернациональ Гмбх | Гетероароматические соединения в качестве ингибиторов ванина |
-
2019
- 2019-12-02 BR BR112021007915-7A patent/BR112021007915A2/pt unknown
- 2019-12-02 WO PCT/EP2019/083252 patent/WO2020114943A1/fr not_active Ceased
- 2019-12-02 CN CN201980078414.7A patent/CN113166104A/zh active Pending
- 2019-12-02 CN CN202210061725.6A patent/CN114478485B/zh active Active
- 2019-12-02 JP JP2021531556A patent/JP7130873B2/ja active Active
- 2019-12-02 TW TW108143868A patent/TWI838430B/zh active
- 2019-12-02 MX MX2021006520A patent/MX2021006520A/es unknown
- 2019-12-02 IL IL283397A patent/IL283397B2/en unknown
- 2019-12-02 CR CR20210294A patent/CR20210294A/es unknown
- 2019-12-02 CA CA3116830A patent/CA3116830A1/fr active Pending
- 2019-12-02 SG SG11202104437XA patent/SG11202104437XA/en unknown
- 2019-12-02 AU AU2019391279A patent/AU2019391279B2/en active Active
- 2019-12-02 US US16/699,799 patent/US11078182B2/en active Active
- 2019-12-02 AR ARP190103518A patent/AR117229A1/es not_active Application Discontinuation
- 2019-12-02 JO JOP/2021/0127A patent/JOP20210127A1/ar unknown
- 2019-12-02 UA UAA202103638A patent/UA128374C2/uk unknown
- 2019-12-02 JO JOP/2021/0128A patent/JOP20210128A1/ar unknown
- 2019-12-02 KR KR1020217020910A patent/KR20210100150A/ko active Pending
- 2019-12-02 EA EA202191476A patent/EA202191476A1/ru unknown
- 2019-12-02 MA MA054378A patent/MA54378A/fr unknown
- 2019-12-02 EP EP19817182.9A patent/EP3891139A1/fr active Pending
- 2019-12-02 PE PE2021000809A patent/PE20211769A1/es unknown
-
2021
- 2021-04-16 DO DO2021000071A patent/DOP2021000071A/es unknown
- 2021-05-06 CL CL2021001198A patent/CL2021001198A1/es unknown
- 2021-05-31 CO CONC2021/0007173A patent/CO2021007173A2/es unknown
- 2021-06-01 PH PH12021551280A patent/PH12021551280A1/en unknown
- 2021-06-01 SA SA521422152A patent/SA521422152B1/ar unknown
- 2021-06-03 EC ECSENADI202140278A patent/ECSP21040278A/es unknown
- 2021-06-25 US US17/358,111 patent/US20220048885A1/en not_active Abandoned
- 2021-12-30 CL CL2021003568A patent/CL2021003568A1/es unknown
-
2022
- 2022-08-24 JP JP2022133354A patent/JP2022188014A/ja not_active Withdrawn
- 2022-11-02 US US18/051,953 patent/US20230295112A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA54378A (fr) | Composés hétéroaromatiques utilisés en tant qu'inhibiteurs de vanine | |
| MA49374A (fr) | Composés hétéroaromatiques utilisés en tant qu'inhibiteurs de vanine | |
| MA52486A (fr) | Pyridazinones utilisés en tant qu'inhibiteurs de parp7 | |
| MA54076A (fr) | 2-amino-n-hétéroaryl-nicotinamides utilisés en tant qu'inhibiteurs de nav1.8 | |
| EP3873468A4 (fr) | 2-amino-n-phényl-nicotinamides utilisés en tant qu'inhibiteurs de nav1.8 | |
| MA43169A (fr) | Composés hétérocycliques utilisés en tant qu'inhibiteurs de pi3k-gamma | |
| MA51846A (fr) | Composés hétérocycliques utilisés en tant qu'inhibiteurs de kinases | |
| MA49888A (fr) | Composés macrocycliques utilisés en tant qu'inhibiteurs de kinase ros1 | |
| MA51438A (fr) | Composés hétérocycliques utilisés en tant qu'inhibiteurs de lsd1 | |
| MA52189A (fr) | Benzothiophènes et composés associés utilisés en tant qu'agonistes de sting | |
| EP3768661A4 (fr) | Composés deutérés utilisés en tant qu'inhibiteurs de rock | |
| MA47099A (fr) | Composés hétéroaromatiques bicycliques utilisés en tant qu'immunomodulateurs | |
| MA56398A (fr) | Composés 2,3-dihydroquinazoline en tant qu'inhibiteurs de nav1.8 | |
| MA45375A (fr) | Composés hétérocycliques utilisés en tant qu'agents antibacteriens | |
| MA47013A (fr) | Composés benzolactames utilisés en tant qu'inhibiteurs de protéine kinase | |
| MA45377A (fr) | Composés hétérocycliques en tant qu'agents antibacteriens | |
| EP3621624A4 (fr) | Composés dinucléotidiques cycliques en tant qu'agonistes sting | |
| MA53377A (fr) | Composés de pyridin-2-one utiles en tant qu'antagonistes de smarca2 | |
| MA51878A (fr) | Composés d'aminothiazole en tant qu'inhibiteurs de c-kit | |
| EP3733671A4 (fr) | Dérivés amino-fluoropipéridines utilisés en tant qu'inhibiteur de kinase | |
| MA49956A (fr) | Composés de pyrimidine utilisés en tant qu'inhibiteurs de kinase jak | |
| EP3733673A4 (fr) | Dérivés d'oxy-fluoropipéridine utilisés en tant qu'inhibiteur de kinase | |
| EP3442488A4 (fr) | Compositions pour l'application topique de composés | |
| EP3442973A4 (fr) | Nouveaux composés utilisés en tant qu'inhibiteurs de l'autotaxine et compositions pharmaceutiques les comprenant | |
| MA42919A (fr) | Composés bicycliques utilisés en tant qu'inhibiteurs d'atx |